• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

5.325 +0.084 (+1.61%)
Delayed Quote Updated: 3:58 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,901
Open 5.230
Bid (Size) 4.850 (2,600)
Ask (Size) 6.180 (100)
Prev. Close 5.240
Today's Range 5.110 - 5.400
52wk Range 1.900 - 10.59
Shares Outstanding 620,290
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Researchers in South Korea Identify New Protein That Controls Brain Cancer Growth
September 28, 2026
Via Investor Brand Network
Injectable Nanodevices Exhibit Potency Against Brain Tumors
September 21, 2026
Via Investor Brand Network

Performance

52-Week Range 49.7% below 52-week high
5.325
1.9052W Low 10.5952W High
1 Week 2.7% below 1-week high
4.911W Low 5.471W High

CNS Pharmaceuticals, Inc. - Common Stock (CNSP) traded between $1.90 and $10.59 over the past 52 weeks and last traded at $5.32, 49.7% below its 52-week high. Over the past week it ranged between $4.91 and $5.47.

Past 12 Months
+4.2%
-11.4%
+6.9%
+129.5%
+0.5%
-40.0%
1W +$0.21
1M -$0.69
3M +$0.34
6M +$3.00
YTD +$0.02
1Y -$3.56

CNSP was -40.0% over the past year, +129.5% over six months, +0.5% year to date, +4.2% in the last week.

12 Months vs Market
CNSP
-40.0%
DIA
+9.9%
SPY
+15.0%
QQQ
+23.7%
IWM
+15.4%

Over the past 12 months CNSP returned -40.0% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.

Volume & Liquidity 1.54× 3-mo avg
Today 10,901 3-mo avg 7.1K
1W
4.5K
1M
4.9K
3M
7.1K
6M
706.9K
YTD
486.7K
1Y
370.0K

CNSP most recently traded 10,901 shares against a 3-month average daily volume of 7.1K.

More News

Read More
Accelerated Biological Aging Could Explain Why Younger Adults are Getting Cancer
September 17, 2026
Via Investor Brand Network
Laser Therapy Shows Promise in Treating Brain Cancer
September 08, 2026
Via Investor Brand Network
Timing of Brain Metastasis Predicts Survival of Colorectal Cancer Patients
September 04, 2026
Via Investor Brand Network
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Business Development Strategy in Virtual Investor Segment
September 01, 2026
Via Investor Brand Network
New T Cell Therapy Could Transform Glioblastoma Care
August 24, 2026
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
September 01, 2026
From CNS Pharmaceuticals, Inc.
Via ACCESS Newswire
Covid-19 Vaccine Could Extend Survival of Brain Cancer Patients
August 27, 2026
Via Investor Brand Network
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Strategic Transformation at Virtual Investor Conference
August 27, 2026
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
August 27, 2026
From CNS Pharmaceuticals, Inc.
Via ACCESS Newswire
Researchers Identify a Protein That Could Be Targeted in Glioblastoma Therapy
August 18, 2026
Via Investor Brand Network
NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 Results as Strategic Pivot Advances
August 12, 2026
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
August 12, 2026
From CNS Pharmaceuticals, Inc.
Via ACCESS Newswire
Focused Ultrasound Shows Promise in Treating Brain Tumors
August 10, 2026
Via Investor Brand Network
Spanish Patient Highlights Risks of Poorly Cooked Pork
August 07, 2026
Via Investor Brand Network
Novel Vitamin B12 Treatment Offers Hope in Brain Cancer Treatment
July 30, 2026
Via Investor Brand Network
Experimental Immunotherapy Offers Hope Against Deadly Pediatric Brain Cancer
July 27, 2026
Via Investor Brand Network
Study Finds No Evidence That Mobile Phones Can Cause Brain Cancer
July 21, 2026
Via Investor Brand Network
Widely Prescribed Thyroid Hormone Could Prevent Pediatric Brain Tumor Recurrence
July 13, 2026
Via Investor Brand Network
New Vaccine Gives Brain Cancer Patients Hope of Longer Survival
July 10, 2026
Via Investor Brand Network
Scientists Find Targeting Enzyme That Could Block Brain Metastases
June 24, 2026
Via Investor Brand Network
WashU Vaccine Could Revolutionize Personalized Glioblastoma Treatment
June 23, 2026
Via Investor Brand Network
Study Links TBI to Higher Mortality Risk Due to Brain Cancer
June 12, 2026
Via Investor Brand Network
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Oversubscribed $22.5 Million Financing and Growth Strategy in Investor Presentation
June 08, 2026
Via Investor Brand Network

Frequently Asked Questions

Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?
CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market
What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?
The current price of CNS Pharmaceuticals, Inc. - Common Stock is 5.325
When was CNS Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 10/02/26 03:58 PM ET
What is the market capitalization of CNS Pharmaceuticals, Inc. - Common Stock?
The market capitalization of CNS Pharmaceuticals, Inc. - Common Stock is 3.30M
How many shares of CNS Pharmaceuticals, Inc. - Common Stock are outstanding?
CNS Pharmaceuticals, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap